The U.S. Food and Drug Administration today approved Nuplazid (pimavanserin) tablets, the first drug approved to treat hallucinations and delusions associated with psychosis experienced by some people with Parkinson’s disease.
from Dementia Big http://ift.tt/1Tlbfvn via alcoholic dementia
http://ift.tt/1O4Yy6b
No comments:
Post a Comment